Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-10-28

FDA Approved: LEFLUNOMIDE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

FDA approved a supplemental application for Leflunomide from Apotex Corp.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leflunomide (Leflunomide)

Snippet

SUPPL AP for LEFLUNOMIDE (LEFLUNOMIDE)